TITLE

Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

AUTHOR(S)
Sterenczak, Katharina A; Meier, Martin; Glage, Silke; Meyer, Matthias; Willenbrock, Saskia; Wefstaedt, Patrick; Dorsch, Martina; Bullerdiek, Jrn; Escobar, Hugo Murua; Hedrich, Hans; Nolte, Ingo
PUB. DATE
January 2012
SOURCE
BMC Cancer;2012, Vol. 12 Issue 1, p284
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Cell lines represent a key tool in cancer research allowing the generation of neoplasias which resemble initial tumours in in-vivo animal models. The characterisation of early tumour development is of major interest in order to evaluate the efficacy of therapeutic agents. Magnetic resonance imaging (MRI) based in-vivo characterisation allows visualisation and characterisation of tumour development in early stages prior to manual palpation. Contrast agents for MRI such as superparamagnetic iron oxide nanoparticles (SPIOs) and manganese chloride (MnCl2) represent powerful tools for the in-vivo characterisation of early stage tumours. In this experimental study, we labelled prostate cancer cells with MnCl2 or SPIOs in vitro and used 1 T MRI for tracing labelled cells in-vitro and 7 T MRI for tracking in an in-vivo animal model. Methods: Labelling of prostate cancer cells CT1258 was established in-vitro with MnCl2 and SPIOs. In-vitro detection of labelled cells in an agar phantom was carried out through 1 T MRI while in-vivo detection was performed using 7 T MRI after subcutaneous (s.c.) injection of labelled cells into NOD-Scid mice (n = 20). The animals were scanned in regular intervals until euthanization. The respective tumour volumes were analysed and corresponding tumourmasses were subjected to histologic examination. Results:MnCl2 in-vitro labelling resulted in no significant metabolic effects on proliferation and cell vitality. In-vitro detection-limit accounted 105 cells for MnCl2 as well as for SPIOs labelling. In-vivo 7 T MRI scans allowed detection of 103 and 104 cells. In-vivo MnCl2 labelled cells were detectable from days 4-16 while SPIO labelling allowed detection until 4 days after s.c. injection.MnCl2 labelled cells were highly tumourigenic in NOD-Scid mice and the tumour volume development was characterised in a time dependent manner. The amount of injected cells correlated with tumour size development and disease progression. Histological analysis of the induced tumour masses demonstrated characteristic morphologies of prostate adenocarcinoma. Conclusions: To the best of our knowledge, this is the first study reporting direct in-vitro MnCl2 labelling and 7 T based in-vivo MRI tracing of cancer cells in a model of prostate cancer. MnCl2 labelling was found to be suitable for in-vivo tracing allowing long detection periods. The labelled cells kept their highly tumourigenic potential in-vivo. Tumour volume development was visualised prior to manual palpation allowing tumour characterisation in early stages of the disease.
ACCESSION #
82353600

 

Related Articles

  • In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles. Yunkai Zhu; Ying Sun; Yaqing Chen; Weiyong Liu; Jun Jiang; Wenbin Guan; Zhongyang Zhang; Yourong Duan // International Journal of Molecular Sciences;2015, Vol. 16 Issue 5, following p9573 

    The prostate specific membrane antigen (PSMA) is broadly overexpressed on prostate cancer (PCa) cell surfaces. In this study, we report the synthesis, characterization, in vitro binding assay, and in vivo magnetic resonance imaging (MRI) evaluation of PSMA targeting superparamagnetic iron oxide...

  • Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis. Chao, Herta H.; Uchio, Edward; Zhang, Sheng; Hu, Sien; Bednarski, Sarah R.; Luo, Xi; Rose, Michal; Concato, John; Li, Chiang-shan R. // BMC Cancer;2012, Vol. 12 Issue 1, p371 

    Background: Despite a lack of consensus regarding effectiveness, androgen deprivation therapy (ADT) is a common treatment for non-metastatic, low-risk prostate cancer. To examine a particular clinical concern regarding the possible impact of ADT on cognition, the current study combined...

  • T1-MRI Fluorescent Iron Oxide Nanoparticles by Microwave Assisted Synthesis. Bhavesh, Riju; Lechuga-Vieco, Ana V.; Ruiz-Cabello, Jesús; Herranz, Fernando // Nanomaterials (2079-4991);2015, Vol. 5 Issue 4, p1880 

    Iron oxide nanoparticles have long been studied as a T2 contrast agent in MRI due to their superparamagnetic behavior. T1-based positive contrast, being much more favorable for clinical application due to brighter and more accurate signaling is, however, still limited to gadolinium- or...

  • Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study. Cherrier, Monique M.; Borghesani, Paul R.; Shelton, Amy L.; Higano, Celestia S. // BMC Cancer;2010, Vol. 10, p1 

    Background: A common treatment option for men with prostate cancer is androgen deprivation therapy (ADT). However, men undergoing ADT may experience physical side effects, changes in quality of life and sometimes psychiatric and cognitive side effects. Methods: In this study, hormone naïve...

  • Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview. Reva, Sergey; Nosov, Alexander; Novikov, Roman; Petrov, Sergey // ISRN Otolaryngology;2014, p1 

    Recent therapeutic advances for managing low-risk prostate cancer include the active surveillance and focal treatment. However, locating a tumor and detecting its volume by adequate sampling is still problematic. Development of predictive biomarkers guiding individual therapeutic choices remains...

  • The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. Marliere, François; Puech, Philippe; Benkirane, Ahmed; Villers, Arnauld; Lemaitre, Laurent; Leroy, Xavier; Betrouni, Nacim; Ouzzane, Adil // World Journal of Urology;Aug2014, Vol. 32 Issue 4, p951 

    Purpose: The purpose of this study was to assess the roles of MRI-targeted biopsies (TB) and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance (AS) for low-risk prostate cancer (PCa) based on the first systematic biopsy (SB) series in another...

  • Chemotherapy of Prostate Cancer by Targeted Nanoparticles Trackable by Magnetic Resonance Imaging. Abdalla, Mohamed O.; Turner, Timothy; Yates, Clayton // ISRN Nanotechnology;2012, p1 

    Prostate cancer (CaP) is the commonest diagnosed malignancy and the second main cause of cancer mortality in males in the United States. Thus, there is an urgent need to develop novel drug delivery systems to improve the chemotherapy option for CaP patients. The goal of this paper is to describe...

  • Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. Harisinghani, Mukesh G.; Barentsz, Jelle; Hahn, Peter F.; Deserno, Willem M.; Tabatabaei, Shahin; van de Kaa, Christine Hulsbergen; de la Rosette, Jean; Weissleder, Ralph // New England Journal of Medicine;6/19/2003, Vol. 348 Issue 25, p2491 

    Background: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial–lymphatic fluid...

  • Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Bratan, Flavie; Niaf, Emilie; Melodelima, Christelle; Chesnais, Anne; Souchon, Rémi; Mège-Lechevallier, Florence; Colombel, Marc; Rouvière, Olivier // European Radiology;Jul2013, Vol. 23 Issue 7, p2019 

    Objectives: To assess factors influencing prostate cancer detection on multiparametric (T2-weighted, diffusion-weighted, and dynamic contrast-enhanced) MRI. Methods: One hundred and seventy-five patients who underwent radical prostatectomy were included. Pre-operative MRI performed at 1.5 T ( n...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics